PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Study confirms safety, cancer-targeting ability of nutrient in broccoli, other vegetables

2011-06-10
(Press-News.org) CORVALLIS, Ore. – Sulforaphane, one of the primary phytochemicals in broccoli and other cruciferous vegetables that helps them prevent cancer, has been shown for the first time to selectively target and kill cancer cells while leaving normal prostate cells healthy and unaffected.

The findings, made by scientists in the Linus Pauling Institute at Oregon State University, are another important step forward for the potential use of sulforaphone in cancer prevention and treatment. Clinical prevention trials are already under way for its use in these areas, particularly prostate and breast cancer.

It appears that sulforaphane, which is found at fairly high levels in broccoli, cauliflower and other cruciferous vegetables, is an inhibitor of histone deacetylase, or HDAC enzymes. HDAC inhibition is one of the more promising fields of cancer treatment and is being targeted from both a pharmaceutical and dietary approach, scientists say.

"It's important to demonstrate that sulforaphane is safe if we propose to use it in cancer prevention or therapies," said Emily Ho, a principal investigator in the Linus Pauling Institute, lead author on the study and associate professor in the OSU Department of Nutrition and Exercise Sciences.

"Just because a phytochemical or nutrient is found in food doesn't always mean its safe, and a lot can also depend on the form or levels consumed," Ho said. "But this does appear to be a phytochemical that can selectively kill cancer cells, and that's always what you look for in cancer therapies."

The findings were published in Molecular Nutrition and Food Research, a professional journal. Research was supported by the National Cancer Institute, National Institute of Environmental Health Sciences and the OSU Agricultural Experiment Station.

The Linus Pauling Institute has conducted some of the leading studies on sulforaphane's role as an HDAC inhibitor – one, but not all, of the mechanisms by which it may help prevent cancer. HDACs are a family of enzymes that, among other things, affect access to DNA and play a role in whether certain genes are expressed or not, such as tumor suppressor genes.

Some of the mechanisms that help prevent inappropriate cell growth – the hallmark of cancer – are circumvented in cancer cells. HDAC inhibitors can help "turn on" these silenced genes and restore normal cellular function.

Previous OSU studies done with mouse models showed that prostate tumor growth was slowed by a diet containing sulforaphane.

"It is well documented that sulforaphane can target cancer cells through multiple chemopreventive mechanisms," the researchers wrote in their study. "Here we show for the first time that sulforaphane selectively targets benign hyperplasia cells and cancerous prostate cells while leaving the normal prostate cells unaffected."

"These findings regarding the relative safety of sulforaphane to normal tissues have significant clinical relevance as the use of sulforaphane moves towards use in human clinical trials," they said.

The results also suggest that consumption of sulforaphane-rich foods should be non-toxic, safe, simple and affordable.

### END


ELSE PRESS RELEASES FROM THIS DATE:

New animal study shows promise for development of Parkinson's disease drug

2011-06-10
Amsterdam, NL, 9 June 2011 – Few treatments for Parkinson's disease (PD) restore function for extended periods. In a new study published today in the inaugural issue issue of the Journal of Parkinson's Disease, an international group of researchers report that platelet-derived growth factor-BB (PDGF-BB) restored function in rodents and shows promise as a clinical candidate drug for treatment of PD. Parkinson's disease is the second most common neurodegenerative disorder, affecting 1𔃀% of the population over the age of 65. It is characterized by loss of brain cells ...

New method for measuring Parkinson's disease prevalence reveals sharp increase in Israel

2011-06-10
Amsterdam, NL, 9 June 2011 – In a new study published today in the inaugural issue of the Journal of Parkinson's Disease, Israeli researchers report that by tracking pharmacy purchases of anti-Parkinson drugs they could estimate the number of Parkinson's disease (PD) cases in a large population. The study identified a sharp rise in PD prevalence from 170/100,000 in 2000 to 256/100,000 in 2007 in Israel, which warrants further investigation. Surprisingly, much of the world lacks accurate figures for the percentage of the population (prevalence) with PD and the rate of ...

Chemistry with sunlight

Chemistry with sunlight
2011-06-10
The idea is simple, says Kevin Moeller, PhD, and yet it has huge implications. All we are recommending is using photovoltaic cells (clean energy) to power electrochemical reactions (clean chemistry). Moeller is the first to admit this isn't new science. "But we hope to change the way people do this kind of chemistry by making a connection for them between two existing technologies," he says. To underscore the simplicity of the idea, Moeller and his co-authors used a $6 solar cell sold on the Internet and intended to power toy cars to run reactions described in an article ...

Confused.com Reveals 56% of Drivers Forget Where They Park

2011-06-10
Confused.com has revealed that 56% of UK drivers have at some point, forgotten where they have parked their car, and 3% have picked up the phone to ask their breakdown service to help them find it. More than 50 in 2,000 drivers in the UK admit to making that call according to a new survey by car insurance comparison site Confused.com. The Confused.com survey has revealed some of the gaffes of UK drivers, which have led them to phone for their breakdown service, like 25% of drivers have locked their keys in the car and 10% of drivers have had to call for their breakdown ...

Landmark study analyzes scientific productivity and impact of the top 100 PD investigators

2011-06-10
Amsterdam, NL, June 9, 2011 – IOS Press is pleased to announce the publication of a landmark study in which both traditional and innovative scientometric approaches have been employed to identify the top 100 Parkinson's disease (PD) investigators since 1985 and measure their scientific productivity as well as the impact of their contributions to the field. The article appears today in the inaugural issue of the Journal of Parkinson's Disease. This milestone analysis has been conducted by Aaron A. Sorensen, a noted expert in the fields of scientometrics and bibliometrics ...

Mayo Clinic-led research team tests alternative approach to treating diabetes

2011-06-10
JACKSONVILLE, Fla. — In a mouse study, scientists at Mayo Clinic Florida have demonstrated the feasibility of a promising new strategy for treating human type 2 diabetes, which affects more than 200 million people worldwide. In type 2 diabetes, the body stops responding efficiently to insulin, a hormone that controls blood sugar. To compensate for the insensitivity to insulin, many diabetes drugs work by boosting insulin levels; for example, by injecting more insulin or by increasing the amount of insulin secreted from the pancreas. The new study, published in the ...

Executive Healthcare Provider EliteHealth Selected by Holman Auto's Executive Team

Executive Healthcare Provider EliteHealth Selected by Holman Autos Executive Team
2011-06-10
A leading provider of executive health and corporate health programs, concierge medical service EliteHealth has been selected by the southern division of Holman Automotive Group - one of the nation's top auto dealership and leasing companies - to provide a Wellness Program for their managerial staff. The move follows a successful implementation of EliteHealth's Executive Wellness Program in 2010, which has provided concierge medical services to 15 of Holman's southern executive management group. More and more companies are recognizing that corporate success is dependent ...

Cancer protein discovery may aid radiation therapy

2011-06-10
BOSTON--Scientists at Dana-Farber Cancer Institute have uncovered a new role for a key cancer protein, a finding that could pave the way for more-effective radiation treatment of a variety of tumors. Many cancers are driven in part by elevated levels of cyclin D1, which allow the cells to escape growth controls and proliferate abnormally. In the new research, reported in the June 9 issue of Nature, researchers discovered that cyclin D1 also helps cancer cells to quickly repair DNA damage caused by radiation treatments, making the tumors resistant to the therapy. Based ...

Penn researchers show new evidence of genetic 'arms race' against malaria

2011-06-10
PHILADELPHIA — For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back. The international team was led by Sarah Tishkoff, a Penn Integrates Knowledge professor with appointments in the genetics department in Penn's Perelman School of Medicine and the biology department of biology in the School of Arts and Sciences, and Wen-Ya Ko, a postdoctoral ...

Physician participation in lethal injection executions should not be banned, argue 2 ethicists

2011-06-10
(Garrison, NY) Should physicians be banned from assisting in a lethal injection execution, or lose professional certification for doing so? A recent ruling by the American Board of Anesthesiology will revoke certification of anesthesiologists who participate in capital punishment, and other medical boards may act similarly. An article in the Hastings Center Report concludes that decertification of physicians participating in lethal injections by a professional certifying organization goes too far—though individual physicians and private medical groups like the AMA are ...

LAST 30 PRESS RELEASES:

Artificial intelligence enhances monitoring of threatened marbled murrelet

The solution to kidney bleeding and recovery lies within a hemostasis sponge, using the inherent capabilities of the kidneys

Sylvester Cancer adding cellular therapy to its arsenal against metastatic melanoma

Study finds biomarkers for psychiatric symptoms in patients with rare genetic condition 22q

Medical school scientist creates therapy to kill hypervirulent bacteria

New study supports psilocybin’s potential as an antidepressant

The Lancet Public Health: Global study reveals stark differences between females and males in major causes of disease burden, underscoring the need for gender-responsive approaches to health

Revealed: face of 75,000-year-old female Neanderthal from cave where species buried their dead

Hepatitis B is globally underassessed and undertreated, especially among women and Asian minorities in the West

Efficient stochastic parallel gradient descent training for on-chip optical processors

Liquid crystal-integrated metasurfaces for an active photonic platform

Unraveling the efficiency losses and improving methods in quantum dot-based infrared up-conversion photodetectors

A novel deep proteomic approach unveils molecular signatures affected by aging and resistance training

High-intensity spatial-mode steerable frequency up-converter toward on-chip integration

Study indicates that cancer patients gain important benefits from genome-matched treatments

Gift to UCR clinic aims to assist local unhoused population

Research breakthrough on birth defect affecting brain size

Researchers offer US roadmap to close the carbon cycle

Precipitation may brighten Colorado River’s future

Identifying risks of human flea infestations in plague-endemic areas of Madagascar

Archaea can be picky parasites

EPA underestimates methane emissions from landfills, urban areas

Feathers, cognition and global consumerism in colonial Amazonia

Satellite images of plants’ fluorescence can predict crop yields

Machine learning tool identifies rare, undiagnosed immune disorders through patients’ electronic health records

MD Anderson researcher Sharon Dent elected to prestigious National Academy of Sciences

Nonmotor seizures may be missed in children, teens

Emergency departments frequently miss signs of epilepsy in children

Unraveling the roles of non-coding DNA explains childhood cancer’s resistance to chemotherapy

Marshall University announces new clinical trial studying the effect of ACL reconstruction on return to play in sports

[Press-News.org] Study confirms safety, cancer-targeting ability of nutrient in broccoli, other vegetables